Oral GLP-1 drugs quiet brain's food craving circuit
Newer oral drugs related to semaglutide medications, such as Ozempic, reduced pleasure-driven eating in mice by quieting a deep brain reward circuit.
This finding could open new avenues for understanding food cravings and potentially treating substance use disorder. The researchers used mice to study the effects of these drugs on eating behavior. The study suggests that these drugs may have a role in modulating the brain's reward system.